Skip to content
drillr.ai
Sign up

MBX

MBX Biosciences, Inc. Common Stock

NASDAQ · Healthcare · Biotechnology · US

$61.72
+0.49%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue224.0K248.0K———
Gross Profit(224.0K)(248.0K)———
Operating Expenses
R&D Expense88.5M79.2M57.4M28.5M21.4M
SG&A Expense29.4M18.9M10.8M6.8M3.8M
General & Admin Expense29.4M18.9M10.8M6.8M3.8M
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses117.9M98.1M68.2M35.3M25.2M
Cost and Expenses117.9M98.1M68.2M35.3M25.2M
Operating Income (EBIT)(117.9M)(98.1M)(68.2M)(35.3M)(25.2M)
Non-Operating
Interest Income2.5M11.1M6.3M2.7M372.0K
Interest Expense————374.0K
Net Interest Income2.5M11.1M6.3M2.7M(2.0K)
Other Non-Op Income/Expense13.6M11.1M6.3M2.7M(974.0K)
Non-Operating Income (excl Interest)(9.8M)(11.1M)(6.3M)(2.7M)600.0K
EBT (Pre-Tax Income)(104.3M)(87.0M)(61.9M)(32.6M)(26.1M)
Income Tax Expense—————
Bottom Line
Net Income(104.3M)(87.0M)(61.9M)(32.6M)(26.1M)
Earnings from Cont. Ops(104.3M)(87.0M)(61.9M)(32.6M)(26.1M)
Earnings from Discont. Ops—————
Bottom Line Net Income(104.3M)(87.0M)(61.9M)(32.6M)(26.1M)
Per Share
Basic EPS($2.40)($2.38)($1.85)($1.02)($0.82)
Diluted EPS($2.40)($2.38)($1.85)($1.02)($0.82)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding47.7M36.5M33.4M31.9M31.9M
Diluted Shares Outstanding47.7M36.5M33.4M31.9M31.9M
Profitability Metrics
EBITDA(107.9M)(86.7M)(61.7M)(32.4M)(25.7M)
D&A253.0K248.0K244.0K157.0K56.0K
EBIT(108.1M)(87.0M)(61.9M)(32.6M)(25.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026